Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 113Colorectal Neoplasms 73Stomach Neoplasms 48Pancreatic Neoplasms 45Rectal Neoplasms 40Neoplasms 29Neoplasm Metastasis 29Colonic Neoplasms 18Esophageal Neoplasms 16Triple Negative Breast Neoplasms 13Adenocarcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Gallbladder Neoplasms 9Bile Duct Neoplasms 8Brain Neoplasms 7Adenocarcinoma Of Esophagus 7Liver Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Cholangiocarcinoma 5Breast Neoplasms, Male 5Somatostatinoma 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Biliary Tract Neoplasms 4Gastrointestinal Neoplasms 3Gastrinoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Solid Tumor 2

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy 1Oxaliplatin 1Mammaplasty 1Intermittent Pneumatic Compression Devices 1Fondaparinux 1Fibrin Tissue Adhesive 1Educational Status 1Dexamethasone 1Counseling 1Cathartics 1Carbohydrates 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Postoperative Complications × Capecitabine × Clear all
NCT00828672 2019-07-10

AXEBEAM

Universitaire Ziekenhuizen KU Leuven

Phase 2 Completed
84 enrolled 19 charts
Gastrointestinal

Postoperative Complications, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡